secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cigna Group (CI)
CIK:        0001739940
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0000950159-23-000157
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cigna appoints Dr. Philip Ozuah to Board of Directors effective June 1, 2023
----------------------------------------------------------------------------

- Dr. Philip Ozuah appointed independent director on Cigna Board effective June 1, 2023.
- Ozuah is President & CEO of Montefiore Medicine, overseeing 13 hospitals and 300 ambulatory sites.
- He brings deep expertise in value-based care and population health from 32 years at Montefiore.
- Over 60% of Cigna's Board has been refreshed in the past five years to enhance diversity.
- Ozuah will serve on the People Resources and Compliance Committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739940/000095015923000157/0000950159-23-000157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739940/000095015923000157/cigna8k.htm
  HTML page:      https://secwatch.observer/filing/0000950159-23-000157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer